Literature DB >> 16314494

Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing.

Huimin Jiang1, Fan Zhang, Takeshi Kurosu, B Matija Peterlin.   

Abstract

Runx1 binds the silencer and represses CD4 transcription in immature thymocytes. In this study, we found that Runx1 inhibits P-TEFb, which contains CycT1, CycT2, or CycK and Cdk9 and stimulates transcriptional elongation by RNA polymerase II (RNAPII) in eukaryotic cells. Indeed, its inhibitory domain, spanning positions 371 to 411, not only bound CycT1 but was required for silencing CD4 transcription in vivo. Our chromatin immunoprecipitation assays revealed that Runx1 inhibits the elongation but not initiation of transcription and that RNAPII is engaged at the CD4 promoter but is unable to elongate in CD4(-) CD8(+) thymoma cells. These results suggest that active repression by Runx1 occurs by blocking the elongation by RNAPII, which may contribute to CD4 silencing during T-cell development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314494      PMCID: PMC1316947          DOI: 10.1128/MCB.25.24.10675-10683.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

Review 1.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Authors:  R Taube; K Fujinaga; J Wimmer; M Barboric; B M Peterlin
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II.

Authors:  M Barboric; R M Nissen; S Kanazawa; N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

5.  Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.

Authors:  G Napolitano; B Majello; P Licciardo; A Giordano; L Lania
Journal:  Gene       Date:  2000-08-22       Impact factor: 3.688

6.  Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

Authors:  S H Chao; D H Price
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

7.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

8.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.

Authors:  S Kanazawa; T Okamoto; B M Peterlin
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

9.  Domains in the SPT5 protein that modulate its transcriptional regulatory properties.

Authors:  D Ivanov; Y T Kwak; J Guo; R B Gaynor
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 10.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more
  21 in total

1.  Transient modification within a pool of CD4 T cells in the maternal spleen.

Authors:  Elizabeth A Bonney; Michelle T Shepard; Peyman Bizargity
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Differential chromatin looping regulates CD4 expression in immature thymocytes.

Authors:  Huimin Jiang; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

3.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

4.  H3K4 tri-methylation provides an epigenetic signature of active enhancers.

Authors:  Aleksandra Pekowska; Touati Benoukraf; Joaquin Zacarias-Cabeza; Mohamed Belhocine; Frederic Koch; Hélène Holota; Jean Imbert; Jean-Christophe Andrau; Pierre Ferrier; Salvatore Spicuglia
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

5.  AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex.

Authors:  Joseph R Biggs; Luke F Peterson; Youhong Zhang; Andrew S Kraft; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2006-08-05       Impact factor: 4.272

6.  Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.

Authors:  S Wotton; A Terry; A Kilbey; A Jenkins; P Herzyk; E Cameron; J C Neil
Journal:  Oncogene       Date:  2008-06-16       Impact factor: 9.867

7.  Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.

Authors:  Mainul Hoque; Michael B Mathews; Tsafi Pe'ery
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

8.  Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.

Authors:  Kamaleldin E Elagib; Ivailo S Mihaylov; Lorrie L Delehanty; Grant C Bullock; Kevin D Ouma; Jill F Caronia; Sara L Gonias; Adam N Goldfarb
Journal:  Blood       Date:  2008-09-09       Impact factor: 22.113

Review 9.  Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.

Authors:  Adam N Goldfarb
Journal:  J Cell Biochem       Date:  2009-06-01       Impact factor: 4.429

10.  Defining the chromatin signature of inducible genes in T cells.

Authors:  Pek S Lim; Kristine Hardy; Karen L Bunting; Lina Ma; Kaiman Peng; Xinxin Chen; Mary F Shannon
Journal:  Genome Biol       Date:  2009-10-06       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.